Notice of Intent for Army/Navy UpToDate Bridge Contract
ID: HT001125NOI0143Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)DEFENSE HEALTH AGENCYFALLS CHURCH, VA, 22042, USA

NAICS

Web Search Portals and All Other Information Services (519290)

PSC

IT AND TELECOM - BUSINESS APPLICATION/APPLICATION DEVELOPMENT SOFTWARE AS A SERVICE (DA10)
Timeline
    Description

    The Defense Health Agency (DHA) intends to award a sole source bridge contract to UpToDate, Inc. for the provision of the UpToDate clinical tool, which serves as a vital resource for military medical personnel. This contract is essential for delivering comprehensive clinical information and guidance to support medical staff across various military treatment facilities under the operational control of DHA. The contract will include a base period of three months with three additional one-month option periods, ensuring continued access to this critical resource. Interested parties may express their capability to respond within 15 days of publication, although the Government's decision to pursue competition remains discretionary; inquiries can be directed to Linda M. Walker or Destiny Wood via the provided email addresses.

    Point(s) of Contact
    Files
    Title
    Posted
    The U.S. Defense Health Agency (DHA) is issuing a Notice of Intent to award a sole source bridge contract to UpToDate, Inc. for the specialty clinical tool, UpToDate. This contract serves military healthcare personnel by providing essential clinical information and guidance. The procurement is consistent with FAR Part 5 regulations and is not a competitive proposal request. The contract's duration includes a base period of three months with three one-month option periods. UpToDate is designated as the primary online resource for military medical staff, aiding in identifying medical issues and guidance across multiple treatment facilities. The applicable NAICS code for this procurement is 519290, and interested parties may express their capability to respond within 15 days of publication, although the Government's decision to pursue competition remains discretionary. Responses must not include solicitation or marketing materials, ensuring submissions are treated with confidentiality and reviewed by authorized personnel only. Contact details are provided for the Contracting Officer and Contract Specialist for inquiries.
    Lifecycle
    Title
    Type
    Similar Opportunities
    Health Care Operations and Other Program Management Support
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is soliciting offers for a federal contract titled "Health Care Operations and Other Program Management Support." This procurement aims to provide program support services to enhance the efficiency and effectiveness of the DHA's healthcare operations, particularly in managing TRICARE Health Plan programs and related activities. The contract, which is set aside for small businesses, will be awarded as a Firm Fixed-Price contract for a period of 33 months, including a 9-month base period and two 12-month option periods, with the possibility of extending services for an additional 6 months. Interested parties must submit their proposals by January 27, 2025, and direct any inquiries to John J. Kelley or Vicki L. Whiteman at the provided contact information.
    Special Notice of Intent - Contracting Support Services
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) is conducting a Sources Sought notice to identify potential contractors capable of providing Contract Support Services (CSS) for the agency. The primary objective is to gather information on industry capabilities to support acquisition and contract management, program management, and related tasks as outlined in the existing Performance Work Statement (PWS). This opportunity is crucial for maintaining operational continuity until a follow-on contract can be awarded, with full performance anticipated to begin on February 15, 2025, for a base period of six months. Interested parties are encouraged to submit their responses and any questions by January 3, 2025, to the designated contacts, Pamela Bryerton and Stephani Preusser, via email.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Active
    Dept Of Defense
    The Department of Defense (DoD) is seeking quotes for a Blanket Purchase Agreement (BPA) and Additional Discount Program (ADP) related to the procurement of pharmaceutical agents as part of its Uniform Formulary (UF) initiative. This procurement aims to establish an effective and integrated pharmacy benefits program for the Military Health System (MHS), focusing on the clinical and cost-effectiveness of newly approved drugs, including neurological agents, antibiotics, oncological agents, and various other pharmaceutical categories. Interested manufacturers must submit their quotes by January 16, 2025, with a pre-quotation teleconference scheduled for January 8, 2025, to discuss the requirements and expectations. For further inquiries, manufacturers can contact Tracy Banks at tracy.e.banks2.civ@health.mil or Patricia Tyson at patricia.a.tyson3.ctr@health.mil.
    Long Range Acquisition Forecast FY25.
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is issuing a Special Notice regarding the Long Range Acquisition Forecast for Fiscal Year 2025. This forecast aims to inform the business community about upcoming procurement plans, including a variety of contracting opportunities that will be periodically updated as priorities evolve. The DHA is focused on enhancing healthcare delivery and operational readiness for military personnel, with significant initiatives such as the Remote Health Readiness Program, which is projected at $2 billion over ten years, and Enterprise Medical Coding services estimated at $300 million over five years. Interested vendors can subscribe to sam.gov for notifications on daily contracting postings, and for further inquiries, they may contact Marco A. Cypert at marco.a.cypert.civ@mail.mil or Kevin Hodge at kevin.d.hodge8.civ@health.mil.
    Notice of Sole-Source Award to Accreditation Council for Graduate Medicine (ACGME)
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is planning a sole-source contract award to the Accreditation Council for Graduate Medical Education (ACGME) for the accreditation of its graduate medical education (GME) programs. This contract, valued at $770,979.39, is essential for maintaining high standards in medical training and quality care across the DHA enterprise, which is based in Falls Church, Virginia. The decision to award this contract noncompetitively is based on market research indicating that ACGME is the sole accrediting body for GME in the United States, ensuring compliance with publicizing requirements under FAR Part 5. The contract is set to commence on January 1, 2025, and interested parties may reach out to Cherish Young at cherish.d.young2.civ@health.mil or 703-681-7270 for further inquiries.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is soliciting quotes for the Pharmacy Uniform Formulary Blanket Purchase Agreement and the Uniform Formulary Additional Discount Program, aimed at establishing an effective pharmacy benefits program for the Military Health System. This procurement involves the evaluation and selection of pharmaceutical agents based on their clinical and cost-effectiveness, with a focus on newly approved drugs that will be reviewed by the Pharmacy and Therapeutics Committee in February 2025. Interested vendors must submit their pricing information, including National Drug Codes (NDCs), by December 19, 2024, and are encouraged to participate in a pre-quotation teleconference on December 4, 2024. For further inquiries, vendors can contact Tracy Banks at tracy.e.banks2.civ@mail.mil or Julia Trang at julia.n.trang.civ@health.mil.
    Lab Reagents for Pathology Dept. at WRNMMC
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract to Roche Diagnostics Corporation for the procurement of specialized lab reagents and consumables necessary for molecular diagnostics testing in the Pathology Department at Walter Reed National Military Medical Center (WRNMMC). This procurement is critical for testing viral pathogens and is supported under the authority for non-competitive purchases, as Roche is the sole supplier of the proprietary materials required for use with the existing Roche medical equipment at WRNMMC. Interested parties may submit their qualifications by January 10, 2025, via email to the primary contact, Ealed Nuru, at ealed.m.nuru.civ@health.mil, with a copy to Erica S. Oh at erica.s.oh.civ@health.mil. The government retains discretion over the contract award process and is not obligated to seek competitive bids despite any expressions of interest received.
    Microbial Testing Supplies - Bridge Contract
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking to award a sole-source bridge contract for microbial testing supplies to Biomerieux Inc., covering the period from October 1, 2024, to September 30, 2025. This procurement is essential for the William Beaumont Army Medical Center Laboratory, as it involves leasing a microbial identification analyzer and a mass spectrometer, along with necessary reagents and middleware/server interface provision. The unique requirements for ATO authorization on DHA networks necessitate this sole-source approach, as Biomerieux is the only contractor capable of meeting these needs without service disruption. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Robyn Villafranco at Robyn.A.Villafranco.civ@health.mil for further details, with the total contract value estimated at $213,334.67.
    Joint Operational Medicine Medical Logistics Capabilities
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) is seeking information on innovative Operational Medicine (OpMed) Medical Logistics (MEDLOG) solutions for the Joint Operational Medicine Information System (JOMIS). The objective is to identify potential solutions that ensure joint interoperability and meet baseline requirements for survivability, patient safety, and quality of care in various operational environments, particularly under Denied, Disrupted, Intermittent, and Low-Bandwidth (DDIL) conditions. This initiative is crucial for enhancing military medical logistics capabilities, as the current Defense Medical Logistics Standard Support (DMLSS) system is set to be decommissioned by February 2028. Interested vendors must submit their responses by December 18, 2025, and can direct inquiries to Elizabeth M. Ruckwardt at elizabeth.m.ruckwardt.civ@health.mil.
    Notice of Intent To Sole Source Full Service & Maintenance Contract for (2) Government Owned Gaumard Manikins Advanced Pediatric HAL Simulator Equipment
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract for full service and maintenance of two Government-owned Gaumard Manikins Advanced Pediatric HAL Simulator Equipment at Naval Hospital Camp Pendleton in California. The contract aims to ensure the proper functioning and maintenance of these specialized simulators, which are critical for training medical personnel in pediatric care. Gaumard Scientific Co, Inc. is the only approved service provider capable of performing the necessary maintenance due to the proprietary nature of the equipment, and the contract will span a base period plus four one-year options, totaling five years if all options are exercised. Interested vendors may submit capability statements to the primary contact, Mimi Kalua Pollard-Hueitt, at mildred.k.pollard-hueitt.civ@health.mil, by 10:00 a.m. Pacific Time on November 25, 2024, to challenge the sole source determination.